Immunohistochemical Ki67 after short-term hormone therapy identifies low-risk breast cancers as reliably as genomic markers

BACKGROUND: The purpose of this study was to test whether immunohistochemical (IHC) Ki67 levels after short-term preoperative hormone therapy (post-Ki67) predict similar numbers of patients with favorable prognoses as genomic markers. RESULTS: Thirty paired cases (60 samples) were enrolled in this s...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Oncotarget
Main Authors: Iwamoto, Takayuki, Katagiri, Toyomasa, Niikura, Naoki, Miyoshi, Yuichiro, Kochi, Mariko, Nogami, Tomohiro, Shien, Tadahiko, Motoki, Takayuki, Taira, Naruto, Omori, Masako, Tokuda, Yutaka, Fujiwara, Toshiyoshi, Doihara, Hiroyoshi, Gyorffy, Balazs, Matsuoka, Junji
פורמט: Artigo
שפה:Inglês
יצא לאור: Impact Journals LLC 2017
נושאים:
Research Paper
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5432244/
https://ncbi.nlm.nih.gov/pubmed/28412725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15385
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים